2025-11-17T18:44:02-06:00 2024-12-31 873231666 PKF O'CONNOR DAVIES ADVISORY LLC 245 PARK AVENUE 12TH FLOOR NEW YORK NY 10167 990 2024-01-01 133299366 AMERICAN ASSOCIATION FOR THE TREATMENT OF OPIOID DEPENDENCE INC AMER 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO PRESIDENT/CEO 2125665555 2025-11-17 1 1 EVA MRUK P00543254 2122862600 2025-11-16 2024 2025-03-06 01:10:19Z AATOD MARK W PARRINO 225 VARICK STREET 4TH FL NEW YORK NY 10014 2160121 0 X WWW.AATOD.ORG X 1985 NY TO ENHANCE THE QUALITY OF PATIENT CARE IN COMPREHENSIVE OPIOID TREATMENT PROGRAMS. 31 30 4 30 0 0 164404 191216 532054 1947977 43 112 16940 20816 713441 2160121 0 0 0 0 580854 611473 0 0 74155 459862 1483321 1040716 2094794 -327275 65327 868043 759669 393060 219359 474983 540310 X TO ENHANCE THE QUALITY OF PATIENT CARE IN TREATMENT PROGRAMS BY PROMOTING THE GROWTH AND DEVELOPMENT OF COMPREHENSIVE OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES. 0 0 1029536 0 1399759 NATIONAL CONFERENCE- AATOD PRODUCES NATIONAL CONFERENCES ON AN EIGHTEEN MONTH CYCLE. THESE CONFERENCES PROVIDE AN OPPORTUNITY TO INTERESTED PARTIES TO LEARN ABOUT THE MOST CURRENT EVIDENCE BASED PRACTICES IN OUR FIELD. 335293 0 335293 RX OPIOID STUDY- TO BETTER UNDERSTAND THE IMPACT OF PRESCRIPTION OPIOID USE ON ADMISSIONS TO OPIOID TREATMENT PROGRAMS. SEVENTY FIVE TREATMENT PROGRAMS PROVIDE TREND ANALYSIS DATA. 147322 0 0 OPIOID TREATMENT PROGRAMS STUDY- TO INCREASE ACCESS TO THE TREATMENT OF OPIOID ADDICTION THROUGH OPIOID TREATMENT PROGRAMS THROUGHOUT THE UNITED STATES OF AMERICA. 82697 0 212925 MEMBERSHIP - A PORTION OF THE MEMBERSHIP DUES RELATES TO RETURN BENEFITS TO THE MEMBERS. BENEFITS INCLUDE EVENT PRIORITY, UP-TO-DATE RESEARCH FINDINGS, AND MORE. 82697 0 212925 1594848 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 4 1 0 0 0 0 0 0 0 0 0 0 0 0 X 31 30 0 0 0 0 1 1 0 1 1 0 0 1 1 0 0 0 0 1 0 0 NY X X MARK PARRINO 2125665555 225 VARICK STREET 4TH FL NEW YORK NY 10014 MARK W PARRINO MPA PRESIDENT/CEO 40.00 X X 243462 0 29393 ALLEGRA SCHORR FIRST V.P. 1.00 X X 0 0 0 ANN JAMIESON SECOND V.P. 1.00 X X 0 0 0 MICHAEL RIZZI TREASURER 1.00 X X 0 0 0 ERIN LACOURT SECRETARY 1.00 X X 0 0 0 RICHARD BILANGI MEMBER-AT-LARGE 1.00 X 0 0 0 JESSICA ALLENDER DIRECTOR 1.00 X 0 0 0 DAVID BLANKENSHIP DIRECTOR 1.00 X 0 0 0 ANGELA BONAGUIDI DIRECTOR 1.00 X 0 0 0 NICHOLAS CAWBY DIRECTOR 1.00 X 0 0 0 MISTY CHALLINOR DIRECTOR 1.00 X 0 0 0 GEORGE COLEY DIRECTOR 1.00 X 0 0 0 BRIAN CRISSMAN DIRECTOR 1.00 X 0 0 0 KENNY HOUSE DIRECTOR 1.00 X 0 0 0 LINDA HURLEY DIRECTOR 1.00 X 0 0 0 JANICE F KAUFFMAN DIRECTOR 1.00 X 0 0 0 JASON KLETTER DIRECTOR 1.00 X 0 0 0 G DAVY KNEESSY DIRECTOR 1.00 X 0 0 0 ROBERT LAMBERT DIRECTOR 1.00 X 0 0 0 CHRISTINE MARTIN DIRECTOR 1.00 X 0 0 0 LIBERTY MARTINEZ DIRECTOR 1.00 X 0 0 0 A DUSTIN METS DIRECTOR 1.00 X 0 0 0 PETER F MORRIS DIRECTOR 1.00 X 0 0 0 JOSH NIRELLA DIRECTOR 1.00 X 0 0 0 OMAR CORRO DIRECTOR 1.00 X 0 0 0 MARGARET B RIZZO DIRECTOR 1.00 X 0 0 0 SHAREL DOWNS DIRECTOR 1.00 X 0 0 0 DINITA SMITH DIRECTOR 1.00 X 0 0 0 NICK STAVROS DIRECTOR 1.00 X 0 0 0 KENNETH STOLLER MD DIRECTOR 1.00 X 0 0 0 JENNIFER STUKEY DIRECTOR 1.00 X 0 0 0 243462 0 29393 1 0 1 0 0 191216 191216 NATIONAL CONFERENCE 900099 1399759 1399759 RX OPIOID STUDY 541720 335293 335293 MEMBERSHIP DUES 900099 212925 212925 1947977 112 112 REFUNDS & CC POINTS 900099 20816 20816 20816 2160121 1947977 0 20928 272855 105623 126636 40596 234281 158363 70472 5446 11305 5362 4923 1020 54870 26026 23895 4949 38162 18101 16619 3442 90883 90883 54217 5000 49217 82641 66854 3578 12209 4364 2486 1525 353 62335 40771 20204 1360 16271 8675 6169 1427 120461 37946 82515 10310 5359 4021 930 961220 950382 8803 2035 3350 1741 1307 302 931 931 954 496 372 86 PROGRAM INCENTIVES 70780 70780 BAD DEBT EXPENSE 4604 4604 2094794 1594848 425791 74155 159931 215249 217316 217359 122745 121455 146548 93702 5874 6181 29626 27563 2994 2063 212635 103660 868043 759669 53888 61319 40274 3600 25287 25000 273611 129440 393060 219359 X 283099 311521 191884 228789 474983 540310 868043 759669 65327 0 X X 0 1 X 1 0 X 218496 119697 333606 164404 191216 1027419 595851 1227805 1565618 532054 1947977 5869305 814347 1347502 1899224 696458 2139193 6896724 0 316551 324233 344463 317588 313692 1616527 316551 324233 344463 317588 313692 1616527 5280197 70 91 43 43 112 359 70 91 43 43 112 359 2277 13055 740 16940 20816 53828 816694 1360648 1900007 713441 2160121 6950911 0.75960 0.75850 0.00010 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2020 AMOUNT: $ 2,277. 2021 AMOUNT: $ 13,055. 2022 AMOUNT: $ 740. 2023 AMOUNT: $ 16,940. 2024 AMOUNT: $ 20,816. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8380 6317 2063 21246 21246 0 2063 RIGHT-OF-USE ASSET 103660 103660 LEASE LIABILITY 129440 129440 X 2160121 0 2160121 0 2160121 2094794 0 2094794 0 2094794 PART X, LINE 2: THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. THE ORGANIZATION IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR YEARS PRIOR TO DECEMBER 31, 2021. X X X 0 0 0 0 0 0 0 1 0 MARK W PARRINO MPA PRESIDENT/CEO 228462 0 15000 0 0 0 11000 0 18393 0 272855 0 0 0 PART I, LINE 7 THE ORGANIZATION PAID A BOARD-APPROVED, PERFORMANCE-BASED BONUS IN 2024. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION'S MEMBERSHIP IS OPEN TO INDIVIDUALS AND STATE OR COUNTRY ASSOCIATIONS INTERESTED IN FURTHERING MEDICATION ASSISTED TREATMENT: A. STATE AND COUNTRY ASSOCIATION MEMBERS (ASSOCIATIONS WITH A MINIMUM OF 3 PROVIDERS): EACH MEMBER IN THIS CLASS NOMINATES A BOD DIRECTOR TO REPRESENT THEM FOR 4 YEAR TERM. B. MEMBERS AT LARGE (INDIVIDUALS WITH EXPERTISE): EACH MEMBER IN THIS CLASS HAS VOTING RIGHTS AT GENERAL MEMBERSHIP MEETINGS FOR 4 YEAR TERM. FORM 990, PART VI, SECTION A, LINE 7A EACH MEMBER STATE OR COUNTRY ASSOCIATION HAS THE RIGHT TO DESIGNATE ONE REPRESENTATIVE TO SERVE ON THE BOARD OF DIRECTORS. THIS DIRECT RIGHT TO APPOINT A BOARD REPRESENTATIVE CONSTITUTES MEMBER POWER TO APPOINT ONE OR MORE MEMBERS OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE PRESIDENT, THE TREASURER, AND FINANCE COMMITTEE BEFORE FILING. THE FINAL FORM 990 IS PROVIDED TO THE FULL BOARD OF DIRECTORS BEFORE E-FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 15A THE EXECUTIVE COMMITTEE, ACTING AS THE COMPENSATION COMMITTEE, CONDUCTS ANNUAL REVIEWS OF THE PRESIDENT'S PERFORMANCE AND COMPENSATION. EVERY THIRD YEAR THE EXECUTIVE COMMITTEE REVIEWS COMPARABILITY DATA AND SETS NEW COMPENSATION LEVELS TO BE REFLECTED IN THE PRESIDENT'S THREE YEAR CONTRACT. THE CONTRACT AS PROPOSED BY THE EXECUTIVE COMMITTEE IS THEN SUBMITTED TO THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. THIS PROCESS LAST OCCURRED IN 2024. ALL DECISIONS WERE DOCUMENTED IN THE MINUTES OF THE BOARD. FORM 990, PART VI, SECTION C, LINE 19 UPON REQUEST, AATOD MAKES AVAILABLE TO THE PUBLIC ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS. FORM 990, PART XII, LINE 2C: THE ORGANIZATION HAS A FINANCE COMMITTEE THAT IS RESPONSIBLE FOR OVERSIGHT OF THE AUDIT AND SELECTION OF THE INDEPENDENT AUDITOR. THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.